Prognostic factors in neuroblastoma.

Area of Science:

• Pediatric Oncology
• Cancer Research
• Clinical Epidemiology

Background:

• Neuroblastoma and ganglioneuroblastoma are significant pediatric cancers.
• Understanding prognostic factors is crucial for optimizing treatment strategies.
• Long-term survival data from large patient cohorts are essential for analysis.

Purpose of the Study:

• To investigate the relative importance of prognostic factors in neuroblastoma survival.
• To analyze the impact of stage, age, and chemotherapy on patient outcomes.
• To identify specific patient subgroups that may benefit from particular interventions.

Main Methods:

• Retrospective analysis of 88 pediatric patients diagnosed with neuroblastoma or ganglioneuroblastoma.
• Utilized Cox regression analysis to assess the significance of prognostic variables.
• Employed adjusted survival curve comparisons to evaluate treatment effects.

Main Results:

• Disease stage was the most significant prognostic factor for survival in initial regression analysis.
• Age demonstrated a weaker but significant effect, particularly in advanced stages (III and IV).
• Combination chemotherapy showed a survival benefit for stage III patients post-non-radical surgery.

Conclusions:

• Disease stage is the primary determinant of neuroblastoma prognosis.
• Younger age (<1 year) is associated with improved survival in advanced stages.
• Chemotherapy is beneficial for stage III patients when complete surgical resection is not achieved.